Attention $KRTL shareholders: We’re proud to announce that our wholly owned subsidiary, KRTL Biotech Inc., has achieved two major regulatory milestones: FDA Facility Establishment Identifier (FEI) number and National Drug Code (NDC) registration. 🎉 A big step forward in…
Attention $KRTL shareholders: We’re proud to announce that our wholly owned subsidiary, KRTL Biotech Inc., has achieved two major regulatory milestones: FDA Facility Establishment Identifier (FEI) number and National Drug Code (NDC) registration. 🎉 A big step forward in pharmaceutical manufacturing!
This is good news. We are marching forward. Once a manufacturing chain is established and we see consistence revenue from the pharma industry this stock will jump.